References
- Woodward DF, Krauss AH, Chen J, Lai RK, Spada CS, Burk RM, Andrews SW, Shi L, Liang Y, Kedzie KM,Chen R, Gil DW, Kharlamb A, Archeampong A, Ling J, Madhu C, Ni J, Rix P, Usansky J, Usansky H, Weber A, Welty D, Yang W, Tang-Liu DD, Garst ME, Brar B, Wheeler LA, Kaplan U. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol. 200 I ;45\(Suppl 4.):5337-345.
- Brubaker RE Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol. 200 I ;45\(Suppl 4.):5347-351.
- Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand. 1000;77(4668–672.
- Warwar RE, Bullock JD.Latanoprost-induced uveitis. Surv Ophthalmol. 1999;43(5):466–468.
- Fechtner RD, Khouri AS,Zimmerman TJ, Bullock J, Feldman R, Kulkarni P, Michael AJ, Realini T, Warwar R. Anterior uveitis associated with. Am J Ophthalmol. 1998;126W:37-4i.
- Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol. 2002;I33(3):403–405.
- Maihofner C, SchloetzerShrehardt U, Guhring H, et al. Expression of cyclo-oxygenase-2 in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1999;40:5827.
- Sharma S, Sharma SC. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems. Indian J Exp Biol. 1997;35(m): 1025–1023.
- Facei L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 1995;92(8):3376–3380. ro Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.